Launched division designed to target specific emerging demographic via detailed market research and data analysis.Create and execute brand strategy including, but not limited to logo and website design, procurement and management of strategic alliances.Developed and executed public Relations Plan resulting in National exposure via Print and digital publications.Manage marketing operational budget.

Managed team of Marketing and Public Relation personnel. Developed and executed Strategic Marketing Plan to ensure sustained growth.Developed and executed digital footprint and PR campaigns.Manage Marketing Budget

Promotion and sales of pharmaceutical products within hospitals, medical offices and pharmacies across multi markets.Managed a large clientele base of physicians, nurses, pharmacists, and administrative staff. Utilized data and reporting to create sales opportunities that resulted in revenue growth.Promoted to Overlay Sales Specialist (2009) responsible for growing market share with in high volume Allergist, Pulmonologist, Pediatric Pulmonolgist and Internist practices through out Northern New Jersey (Newark, Elizabeth, East Orange, Montclair, Union, etc.)AWARDS FOR OUTSTANDING SALES & LEADERSHIP PERFORMANCE2009 The Distinguished Performance rating - highest performance rating at AstraZeneca Pharmaceuticals. 2009 Summit Achievement Award - surpassed company objective of 20% Symbicort NRx market share for more than 4 consecutive months (achieved over 30%).2009 Recognized for Outstanding Performance by Senior Sales Management Team.2009 Winner of the “Nexium Now” Prevacid share gap change contest.2009 Q3 Kudos Award for Outstanding Cross Portfolio Performance.2008 Nexium Purple Pinnacle Achievement Award.2004 Philadelphia Business Center Leadership Award

Direct sales to Gastroenterologists, Cardiologists and Primary Care.Portfolio of Products: Nexium (Gastroenterology) and Toprol XL (Cardiology).AWARDSCircle of Excellence Award for demonstrating leadership and consistently exceeding sales goals set by AstraZeneca.

• Direct sales of Scheduled 3 long acting Opioid, Kadian to Specialists and Pharmacists.